The CFTC approved perps on individual stocks on November 3, but no exchange has launched yet and a lawsuit is pending. Here's how they work, who has filed, and what it means for Hyperliquid and $HYPE.
🏛️ Crypto's favorite trading tool just got a green light to trade stocks on US exchanges. It's also already in court.
On November 3, the CFTC cleared perpetual futures tied to individual US stocks, known as "equity perps." The agency said they're approved as security futures, which puts them under joint CFTC and SEC oversight. It's the first time they can legally list on regulated US venues.
🔍 What a perp is, in plain words.
A perpetual future is a contract that tracks a price and never expires. Traders can hold it as long as they like, using leverage, with a funding payment keeping it close to the real price. It's the product that made crypto derivatives huge. CME's existing single-stock futures expire on set dates and must be rolled over, which is the key difference.
📋 Who's lined up.
Coinbase Derivatives, Kalshi, Bitnomial (Kraken's parent) and OG.com have filed rules. Kraken's filing names 10 stocks, including Tesla, Nvidia, Apple, Microsoft and Amazon, and Kalshi's reportedly covers 58 stocks and ETFs. None has announced a launch date yet, and final lists aren't confirmed.
⚖️ The fight has already started.
Hours after the approval, the Capital Markets Alliance, a group backed by Cboe and Citadel Securities, sued in New York federal court. It argues these contracts are really security-based swaps under the SEC's exclusive authority, and it wants the approval overturned and trading blocked while the case runs. The CFTC called the suit "troubling" interference with regulated markets. A court hasn't ruled, and a lawsuit doesn't prove the approval was wrong.
📉 About leverage.
Because they're classified as security futures, US stock perps fall under joint CFTC and SEC margin rules. Offshore platforms have offered 20x and, on some index contracts, up to 50x. So, the US version is expected to be tamer, not wilder.
🔗 Where Hyperliquid fits.
Hyperliquid is where most on chain stock perps trade today, with about $4.1 billion in open interest on its stock and commodity markets. It still blocks US residents, and the approval covers only CFTC-registered exchanges. The effect cuts both ways: it validates the product, and it could bring regulated competition. NYSE owner ICE also invested in tradeXYZ, which builds markets on Hyperliquid's technology.
✅ What this means for you
If you trade perps, nothing changes today. No US venue is live yet, and offshore rules and leverage are different. Treat any US launch date as unconfirmed until it's announced.
If you're on the sidelines, this is a "watch, don't chase" story. The legal fight could take months, and the outcome decides who regulates these products.
If you hold $HYPE, the approval is a mixed signal: good for the idea, uncertain for the competition. It's not a price forecast.
🟢 Bullish scenario
The court backs the CFTC, US venues launch with modest leverage, and perps become a mainstream tool that brings new users to on chain markets too.
🔴 Risk scenario
The court sides with the challengers, the approval is blocked, and regulated stock perps are delayed for a long time.
👀 Three things to watch
1️⃣ The court case: does a judge pause trading while it runs?
2️⃣ Launch dates from Coinbase, Kalshi, Bitnomial or OG.com
3️⃣ Hyperliquid's open interest and $HYPE's reaction
💡 The key takeaway
Wall Street just borrowed a crypto product, and part of Wall Street is suing to stop it. Approved is not the same as launched.
The real question isn't whether stock perps are coming. It's who gets to regulate them, and who profits first.
That is the part worth watching.
This post is for informational and educational purposes only and is not financial advice. Crypto markets are volatile. Always conduct your own research before making financial decisions.
#BinanceSquare #Hyperliquid #HYPE #CFTC #PerpetualFutures
